BRAINLIFE Brain Tumor Medical Database

Melatonin

Home > Database > Integrative Medicine > Melatonin

Contents

Search


Cancer Research


Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC
Light during darkness, melatonin suppression and cancer progression
Neuroendocrinol Lett 2002 Jul;23 Suppl 2:52-6

Lissoni P
Is there a role for melatonin in supportive care?
Support Care Cancer 2002 Mar;10(2):110-6

 Abstract

Sauer LA, Dauchy RT, Blask DE
Polyunsaturated fatty acids, melatonin, and cancer prevention
Biochem Pharmacol 2001 Jun 15;61(12):1455-62


Glioblastoma


González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Alvarez-García V, Sánchez-Barceló EJ, Cos S.
Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells
Oncol Rep. 2010 Apr;23(4):1173-8.
  Abstract

Lissoni P, Meregalli S, Nosetto L, Barni S, Tancini G, Fossati V, Maestroni G
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
Oncology 1996 Jan-Feb;53(1):43-6
 Abstract


Gliomas


Rincon Castro LM, Gallant M, Niles LP
Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells
J Neurochem. 2005 Dec;95(5):1227-36.

Vanesa Martín, Federico Herrera, Pilar Carrera-Gonzalez, Guillermo García-Santos, Isaac Antolín, Jezabel Rodriguez-Blanco and Carmen Rodriguez
Intracellular Signaling Pathways Involved in the Cell Growth Inhibition of Glioma Cells by Melatonin
Cancer Research, 66, 1081-1088, January 15, 2006

Wang J, Hao H, Yao L, Zhang X, Zhao S, Ling EA, Hao A, Li G.
Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells.
J Pineal Res. 2012 Feb 9;. [Epub ahead of print]
  Abstract |   Related articles


Metastatic Tumors


Berk L, Berkey B, Rich T, Hrushesky W, Blask D, Gallagher M, Kudrimoti M, McGarry RC, Suh J, Mehta M.
Randomized phase II trial of high-dose melatonin and radiation therapy for rpa class 2 patients with brain metastases (RTOG 0119).
Int J Radiat Oncol Biol Phys. 2007 Apr 5; [Epub ahead of print]
PMID: 17418968 [PubMed - as supplied by publisher]

Lissoni P, Barni S, Ardizzoia A, Tancini G, Conti A, Maestroni G
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms
Cancer 1994 Feb 1;73(3):699-701


Monograph


Barrie Cassileth and K. Simon Yeung
Melatonin (N-acetyl-methoxytryptamine)
10/11/2002 Memorial Sloan-Kettering Cancer Center (HTML Full Text)


Non-CNS Tumors


Barni S, Lissoni P, Cazzaniga M, Ardizzoia A, Meregalli S, Fossati V, Fumagalli L, Brivio F, Tancini G
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
Oncology 1995 May-Jun;52(3):243-5

Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G
Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial
J Pineal Res. 2003 Aug;35(1):12-5

Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ
Anti-angiogenic activity of melatonin in advanced cancer patients
Neuroendocrinol Lett 2001;22(1):45-7

Lissoni P, Barni S, Mandala M, Ardizzoia A, Paolorossi F, Vaghi M, Longarini R, Malugani F, Tancini G
Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status
Eur J Cancer 1999 Nov;35(12):1688-92

Lissoni P, Paolorossi F, Ardizzoia A, Barni S, Chilelli M, Mancuso M, Tancini G, Conti A, Maestroni GJ
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
J Pineal Res 1997 Aug;23(1):15-9

Lissoni P, Brivio O, Brivio F, Barni S, Tancini G, Crippa D, Meregalli S
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma
J Pineal Res 1996 Nov;21(4):239-42

Lissoni P, Barni S, Ardizzoia A, Paolorossi F, Crispino S, Tancini G, Tisi E, Archili C, De Toma D, Pipino G, et al
Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin
Oncology 1992;49(5):336-9

Neri B, de Leonardis V, Gemelli MT, di Loro F, Mottola A, Ponchietti R, Raugei A, Cini G
Melatonin as biological response modifier in cancer patients
Anticancer Res 1998 Mar-Apr;18(2B):1329-32

 

This website is certified by Health On the Net Foundation. Click to verify. HOMEARCHIVES OF NEURO-ONCOLOGYCURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTS
SERVICES: About BrainLife | Brain Tumor Medical Database | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications

This site complies with the HONcode standard for trustworthy health information: verify here bottom